The PREEMPT Act directs the Secretary of Health and Human Services to issue guidance to states within 180 days on which tests for screening and early detecting preeclampsia should be covered under Medicaid and the Children's Health Insurance Program. Preeclampsia is a serious pregnancy complication that affects 5 to 8 percent of pregnancies and is a leading cause of maternal death and illness in the United States, with particularly high mortality rates among Black women. The bill requires the guidance to address best practices for improving outcomes through early screening and detection, and to specify which tests—including advanced biomarker tests approved by the FDA or performed by certified clinical laboratories—states may cover as medical assistance. The Secretary must also provide technical assistance to states within 30 days if they request help determining whether to cover specific preeclampsia detection tests. The bill contains no direct federal funding requirements, as states will determine whether to adopt the guidance and cover these tests under their existing Medicaid programs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.